Lv4
600 积分 2025-10-21 加入
Efficacy and safety of dabrafenib plus trametinib in adults with differentiated thyroid cancer: a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
The B cell receptor–mTOR signaling axis restricts the accumulation of lung tissue-resident memory B cells after influenza infection
3个月前
已完结
Chinese midwives’ experience of providing continuity of care to labouring women
3个月前
已完结
Vemurafenib in patients with BRAFV600E-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial
4个月前
已完结
Efficacy and Tolerability of Vemurafenib in Patients with BRAFV600E -Positive Papillary Thyroid Cancer: M.D. Anderson Cancer Center Off Label Experience
5个月前
已完结
Response to Targeted Therapy inBRAFMutant Anaplastic Thyroid Cancer
6个月前
已关闭
Response to Targeted Therapy inBRAFMutant Anaplastic Thyroid Cancer
6个月前
已完结
Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience
8个月前
已完结
Heterogeneity of tertiary lymphoid structures predicts the response to neoadjuvant therapy and immune microenvironment characteristics in triple-negative breast cancer
9个月前
已完结
Heterogeneity of tertiary lymphoid structures predicts the response to neoadjuvant therapy and immune microenvironment characteristics in triple-negative breast cancer
9个月前
已完结
皖公网安备34019202002308
